Trial intelligence / Profile preview

Insulin Dose Calculation for Mixed Meals in Pediatric T1DM

NCT04124302Phase 4Completed

Sponsor
Medical University of Warsaw
Start
Oct 2019
Primary completion
Mar 2024
Modality
Peptides, Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 4 trial of insulin glulisine, insulin aspart, insulin lispro in type 1 diabetes mellitus (T1D), sponsored by Medical University of Warsaw. Started Oct 2019; status: completed.

02

Drugs

insulin glulisineinsulin aspartinsulin lispro
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT04124302.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04124302.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call